M&A in the Pharmaceuticals sector in 2017. Prim acquires Anota for €1.23M.

14/12/2017
Diego Gutiérrez
M&A in the Pharmaceuticals sector in 2017. Prim acquires Anota for €1.23M.

We take a look at the main M&A transactions in the Spanish pharmaceutical sector in 2017. In addition, we analyse the purchase of Anota, specialised in distribution for pharmacies and orthopaedics, by Grupo Prim for €1.23M.

We take a look at the main M&A transactions in the Spanish pharmaceutical sector in 2017. In addition, we analyse the purchase of Anota, specialised in distribution for pharmacies and orthopaedics, by Grupo Prim for €1.23M.

About Anota

Anota is a company dedicated to the design, development, manufacture and distribution of technical aids and sports medicine products in the pharmacy and orthopaedic channel in the area of orthotics, podiatry, therapeutic compliance systems and technical aids.

Founded in 1990 with headquarters in Sabadell and offices in Barcelona and Madrid, the company achieved a turnover of €3.2M last year.

 

About Prim

Prim is a privately owned Spanish business group listed on the Madrid Stock Exchange since 1985. The Group is a reference in the hospital and orthopaedic supplies market, in physiotherapy, thalassotherapy, thermalism, spa, rehabilitation, geriatrics and technical aids. Its activity is divided into six divisions: Hospitals, Orthopaedics, Orthopaedic Clinics, Physiotherapy and Rehabilitation, Pharma and Spa.

It is the leading supplier of healthcare products and services in the Spanish market, with more than 22,000 references in its product portfolio. The Prim Group closed the last financial year with an increase in turnover of 11%, reaching €110.1M, with a net profit of €11.26M (compared to €10.7M in 2015) and a margin on sales of 10.24%. Its ebitda was €15M, 12.7% higher than in 2016, and its financial debt was also reduced by 24.4% last year, with a volume of €1.6M.

Prim acquires distributor Anota for €1.23m

Prim, a company dedicated to the supply of hospital and orthopaedic devices, has acquired the distribution company for pharmacies and orthopaedics Anota for €1.23m. The transaction will be supplemented by a variable portion that will be subject to the results of the acquired company between 2019 and 2021.

This operation reinforces the Prim Group's presence in this channel, allowing it to continue to make progress in its growth strategy within the healthcare sector, thanks to the complementary nature of the structures of the two companies in operational terms, as well as in terms of their distribution and sales network and their range of products.

Top M&A transactions in the Pharmaceutical sector in 2017

Lastest news

The State of Technology M&A in Spain | October 2026 analysis

En octubre de 2026 hubo 37 operaciones de M&A tecnológico en España: 16 fueron adquisiciones corporativas, inversiones de private equity, fusiones o tomas de participación, y 21 fueron rondas de venture capital. El 62,2% de las operaciones (23 de 37) fueron...

Webinar | How much does your business depend on you?

IMPORTANT INFORMATION: Registration for and participation in the webinars are completely anonymous to third parties. If, for a month, you were unable to have a say in important decisions, what would happen in your company? Your company can grow, be profitable and have good...

Notable technology M&A deals in Spain | September 2026 Analysis

Technology M&A in Spain totalled 61 identified transactions by the end of September 2026, the highest figure in the monthly series we have been publishing since May. Of these, 41 were acquisitions, private equity investments, asset purchases, joint ventures or takeovers...

Baker Tilly advises Invelon on the acquisition of byAR

In September 2026, Invelon, a Spanish technology company specialising in virtual, augmented and mixed reality, completed the acquisition of a majority stake in byAR, a Portuguese company specialising in museum exhibitions and the development of spaces...

Do you want to sell or buy a company?

We are experts in M&A transactions in the technology sector.

Subscribe to our newsletter

    On which topic would you like to receive information?